The State of Immune Checkpoint Modulators: Today and Tomorrow

The cancer immunotherapy market is projected to reach close to $125 billion worldwide by 2024, rising from $37.5 billion in 2015.

A new report explores the current and future state of Immune Checkpoint Modulators (ICM).

This new trends report features data and insights from Pharma Playbook to explore the current and future state of Immune Checkpoint Modulators (ICM).

Using Signals Analytics’ Pharma Playbook configurable data and analytics platform, this report will give you powerful insights into this and more: 

  • The Origin & Leading Players of ICM

  • Research & Development Activity Surrounding ICM

  • ICM Use Cases in Oncology

  • Potential of ICM Beyond Cancer

Download this report today!